ICAD Inc
NASDAQ:ICAD

Watchlist Manager
ICAD Inc Logo
ICAD Inc
NASDAQ:ICAD
Watchlist
Price: 1.72 USD 2.08%
Market Cap: 45.6m USD
Have any thoughts about
ICAD Inc?
Write Note

ICAD Inc
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ICAD Inc
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
ICAD Inc
NASDAQ:ICAD
Intangible Assets
$111k
CAGR 3-Years
-47%
CAGR 5-Years
-39%
CAGR 10-Years
-40%
Veeva Systems Inc
NYSE:VEEV
Intangible Assets
$48.5m
CAGR 3-Years
-22%
CAGR 5-Years
20%
CAGR 10-Years
22%
Inspire Medical Systems Inc
NYSE:INSP
Intangible Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Intangible Assets
$27.3m
CAGR 3-Years
42%
CAGR 5-Years
133%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Intangible Assets
$253.5m
CAGR 3-Years
-7%
CAGR 5-Years
4%
CAGR 10-Years
12%
W
Waystar Holding Corp
NASDAQ:WAY
Intangible Assets
$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ICAD Inc
Glance View

Market Cap
45.3m USD
Industry
Health Care

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.

ICAD Intrinsic Value
1.67 USD
Overvaluation 3%
Intrinsic Value
Price

See Also

What is ICAD Inc's Intangible Assets?
Intangible Assets
111k USD

Based on the financial report for Sep 30, 2024, ICAD Inc's Intangible Assets amounts to 111k USD.

What is ICAD Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
-40%

Over the last year, the Intangible Assets growth was -38%. The average annual Intangible Assets growth rates for ICAD Inc have been -47% over the past three years , -39% over the past five years , and -40% over the past ten years .

Back to Top